Unlike most IVRS systems, which are built and deployed individually for each protocol, Trident’s IWR parameter driven system allows biopharmaceuticals to avoid the cost, risk, delay, and tedium of the “code and validate each time” norm. In 80% of studies, there is no need to customize.
For functionality that falls outside of parameters – complex dosing titration rules, for example – the variability can be handled with reusable custom code and custom data modules inserted into the existing system. This exclusive Trident ability to use plug-ins, combined with its parameter driven system, means Trident can handle hundreds of phase II-IV protocols simultaneously.